Hong Kong

Ynno Med

2023 2023 Winner | Venture Winner Science Start-ups (Falling Walls Venture)

By 2050, antimicrobial infections are projected to cause 10 million deaths worldwide, outracing cancers. Therefore, new antimicrobial agents are urgently needed before the existing ones become ineffective.

Ynno Med developed an AI-assisted platform for discovering new drugs, specializing in the infectious disease area. They address the unmet clinical needs of new antimicrobial agents tackling antimicrobial resistance. As a university spin-off company, YnnoMed is commercializing the scientific and technological findings obtained from research activities to utilize the otherwise unexploited knowledge. As a drug R&D company, their goal is to design, develop, and distribute first-in-class antimicrobial medicines that can treat current antibiotic-resistant bacterial infections and suppress the generation of new antimicrobial resistance. Additionally, they can also provide drug design and discovery services, using their technology to facilitate industrial development.

Content by this speaker

Explore more content of Falling Walls

Events with Ynno Med

Tue | Nov 07, 2023 | 02.00 PM - 04.00 PM Berlin Time

Falling Walls Venture Pitches – Session 3: Health Solutions

Further Activities to have a look at